IFNB1, interferon beta 1, 3456

N. diseases: 426; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE The administration of the R. capsulatus PG lipopolysaccharide was shown to induce interferon-β synthesis, both in healthy and influenza A virus-infected mice, and to promote production of antiviral antibodies in the blood of the influenza-infected animals. 31720016 2020
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Levels of cytokines, including TNF-α, IL-6, IL-10, and type I IFN (IFN-α and IFN-β), in bronchoalveolar lavage fluid (BALF) were altered after IAV infection; in particular, IFN-α and IFN-β levels were significantly suppressed in the BALF of DIO mice. 30967261 2019
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Together, these data elucidate that lncRNA ISR is regulated by <i>RIG-I</i>-dependent signaling that governs IFN-β production during IAV infection, and has an inhibitory capacity in viral replication. 31623059 2019
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 AlteredExpression disease BEFREE In contrast, TLR3-mutated fibroblasts produce lower levels of IFN-β and -λ, and display enhanced viral susceptibility, upon IAV infection. 31217193 2019
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Furthermore, unlike IFNAR1, IFNAR2 was sufficient to generate protection from lethal IAV infection when stimulated with IFN-β. 30473701 2018
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE IFN-β and IFN-λs were induced in NHNE and ARNE cells up to 3 days after IAV infection. 29288502 2018
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE In this chapter, we describe molecular methods for examining necrosome activation in response to the cytokines TNF-α, IFN-β, and IFN-γ, and upon infection with influenza A virus (IAV). 30136233 2018
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 AlteredExpression disease BEFREE Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes. 29748576 2018
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 AlteredExpression disease BEFREE The results of the present study demonstrated that mice infected with NS1‑expressing influenza A H1N1 virus had lower expression levels of IFNβ in the lung. 28765967 2017
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Influenza A Virus PA Antagonizes Interferon-β by Interacting with Interferon Regulatory Factor 3. 28955326 2017
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 AlteredExpression disease BEFREE Influenza A virus non-structural protein 1 (NS1) antagonizes interferon response through diverse strategies, particularly by inhibiting the activation of interferon regulatory factor 3 (IRF3) and IFN-β transcription. 28717359 2017
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Single-cell studies of IFN-β promoter activation by wild-type and NS1-defective influenza A viruses. 27983470 2017
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 AlteredExpression disease BEFREE Using IFN regulatory factor 3 (IRF3) phosphorylation as a marker of activation of the IFN induction cascade that occurs upstream of the IFN-β promoter, we demonstrate strong activation of the IFN induction cascade in A549 cells infected with a variety of influenza A viruses in the presence of cycloheximide or nucleoprotein (NP) small interfering RNA (siRNA), which inhibits viral protein synthesis and thus complementary ribonucleoprotein (cRNP) and progeny viral RNP (vRNP) synthesis. 24478437 2014
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Three dimensional analysis of drug-drug interactions revealed that IFN-λ1 interacted with IFN-β and oseltamivir carboxylate in an additive or synergistic manner, respectively, to inhibit influenza A virus replication in human airway epithelial cells. 25245230 2014
CUI: C2062441
Disease: Influenza A
Influenza A
0.100 Biomarker disease BEFREE Finally, we compared the effect of PB1-F2 variants taken from several IAV strains on IFN-β expression and found that PB1-F2-mediated IFN-β induction is significantly influenced by its amino acid sequence, demonstrating its importance in the host cell response triggered by IAV infection. 20844191 2010